Immunofluorescence kit for detecting E-Cadherin expression of peripheral blood circulating tumor cells of patient with hepatocellular carcinoma and method
A technology of peripheral blood circulation and tumor cells, applied in biological tests, measurement devices, material inspection products, etc., can solve the problems of inability to evaluate patients, false negatives, false positives of E-Cadherin real-time dynamic status, etc., to reduce the loss of cells, Good stability and avoid edge effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0044] Example 1
[0045] 1. Rinse the filter of circulating tumor cell separator (YZYMED-A10)
[0046] a) Open the upper and lower plugs of the filter and place the filter on the rinse support;
[0047] b) Add about 2mL of 75% medical alcohol to the filter with a pasteurizer and let it naturally filter out from the lower mouth of the filter.
[0048] c) Add 8 mL of physiological saline to the filter for rinsing, remove the residual alcohol in the filter, and naturally filter out the physiological saline;
[0049] d) Repeat step 3 twice, leave a proper amount of physiological saline to ensure that the filter membrane is wet, and install the lower plug of the filter.
[0050] Note: If alcohol cannot be filtered out naturally or is filtered out too slowly during the filter rinse process, please discard the filter immediately.
[0051] 2. Using immunofluorescence to detect the expression of E-Cadherin in circulating tumor cells in the peripheral blood of patients with hepatocellular carcinom...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap